Stockreport

Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook [Yahoo! Finance]

Evotec SE  (EVO) 
NASDAQ:AMEX Investor Relations: eatonvance.com
PDF Evotec SE (NASDAQ: EVO ) for 11 euro ($11.44) per share in cash, implying a fully diluted equity value of 2.0 billion euro. This move comes after prolonged efforts to [Read more]